Article citationsMore>>

Kim, J.K., Marco, M.R., Roxburgh, C.S.D., Chen, C.T., Cercek, A., Strombom, P., et al. (2022) Survival after Induction Chemotherapy and Chemoradiation versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer. The Oncologist, 27, 380-388.
https://doi.org/10.1093/oncolo/oyac025

has been cited by the following article:

• TITLE: Current Status and Research Progress of Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer

  AUTHORS: Junjian Liu, Tian Wei, Zhiping Xiang, Yinlu Ding

  KEYWORDS: Locally Advanced Gastric Cancer, Adjuvant Chemotherapy, Neoadjuvant Chemotherapy

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.11 No.3, March 30, 2023

  ABSTRACT: Gastric cancer is one of the most common malignant tumours worldwide, with a high degree of malignancy and a poor prognosis. While early gastric cancer can be cured by surgical treatment, locally advanced gastric cancer requires neoadjuvant therapy to shrink the tumour, suppress potential metastases, achieve down-staging, and provide patients with the opportunity for radical surgery to prolong their survival. This article reviews the current status and progress of neoadjuvant chemotherapy for locally advanced gastric cancer.